Heading to the Hill

Not only is FDA interested in learning more about direct-to-consumer genetic tests — the deputy director of the device evaluation section wrote a letter to the Pathway Genomics CEO asking him to provide the FDA clearance or approval number for Genetic Health Report or explain why he thinks it doesn't need clearance — so is the US House of Representatives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.